XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Assets and Financial Liabilities
12 Months Ended
Dec. 31, 2021
Disclosure Of Financial Instruments [Abstract]  
Financial Assets and Financial Liabilities

11.

FINANCIAL ASSETS AND FINANCIAL LIABILITIES

11(a)Other financial assets and liabilities

 

As of December 31,

 

 

2021

 

2020

 

 

US$’000

 

US$’000

 

Financial assets at fair value through other comprehensive income

 

 

 

 

 

 

Equity instrument (Note 11(d))

 

2,929

 

 

2,271

 

 

 

2,929

 

 

2,271

 

Financial assets at fair value through profit or loss

 

 

 

 

 

 

Foreign exchange forward contracts (Note 11(c))

 

249

 

 

 

 

 

249

 

 

 

 

 

(i)

Financial assets and liabilities at fair value through profit or loss

Financial assets and liabilities at fair value through profit or loss reflect the changes in fair value of those foreign exchange forward contracts that are not designated in hedge relationships, but are intended to reduce the level of foreign currency risk for expected sales and purchase transactions.  

 

 

(ii)

Financial assets at fair value through other comprehensive income - unquoted equity instrument

On January 1, 2018, the date of initial application of IFRS 9, our Company elected to reclassify its unquoted equity instrument in Thai Metal Processing Co., Ltd (“TMP”), which is engaged in the fabrication of copper rods, from financial assets – available-for-sale to financial assets at fair value through other comprehensive income due to the investment being hold as a long-term strategic investment and not expected to be sold in the short to medium term. During the years ended December 31, 2021, 2020, and 2019, our Company received dividends of $106, $108, and $109 from TMP, respectively, which were recorded in other income (Note 7(e)) in the consolidated income statements.

    

  

 

11.

FINANCIAL ASSETS AND FINANCIAL LIABILITIES (continued)

11(b)Interest-bearing loans and borrowings

Under the line of credit arrangements for short-term debt with our Company’s banks, our Company may borrow up to approximately $270,094 and $264,162 as of December 31, 2021 and 2020, respectively, on such terms as our Company and the banks may mutually agree upon. These arrangements do not have termination dates but are reviewed annually for renewal. As of December 31, 2021 and 2020, the unused portion of the credit lines was approximately $153,250 and $200,340, respectively, which included unused letters of credit amounting to $66,820 and $95,034, respectively.

Letters of credit are issued by our Company in the ordinary course of business through major financial institutions as required by certain vendor contracts. As of December 31, 2021 and 2020, our Company had open letters of credit amounting to $50,633 and $18,077, respectively. Liabilities relating to the opened letters of credit are included in current liabilities.

Interest bearing loans and borrowings are including current portion $62,083 and $10,131 as of December 31, 2021 and 2020, respectively.

 

 

As of December 31,

 

 

2021

 

2020

 

 

Interest rate

 

Maturity

Local currency

 

 

 

Interest rate

Maturity

Local currency

 

 

 

 

%

 

 

‘000

US$’000

 

%

 

‘000

US$’000

 

Interest-bearing loans and borrowings

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bank loans (including bank overdrafts US$1,995 in 2021)

 

3.07

 

Mar. 2044

AUD$7,458

 

5,410

 

3.07

Mar. 2045

AUD$4,883

 

3,764

 

Bank loans

3.85~4.53

 

Jul . 2022

RMB$41,751

 

6,552

 

4.50 ~ 4.90

Jun. 2021

RMB$17,800

 

2,736

 

Trust receipt

0.7~3.3

 

Jun. 2022

THB$1,648,835

 

49,729

 

0.9 ~ 1.0

Mar. 2021

THB$74,176

 

2,488

 

Bank loan (Trust receipt in 2020)

 

1.98

 

Dec. 2022

SGD$5,000

 

3,696

 

2.32

Apr. 2021

SGD$6,332

 

4,793

 

Total

 

 

 

 

 

 

65,387

 

 

 

 

 

13,781

 

 

 

11.

FINANCIAL ASSETS AND FINANCIAL LIABILITIES (continued)

11(c)Hedging activities and derivatives

 

(i)

   Commodity price risk

Our Company purchases copper on an ongoing basis as its operating activities require a continuous supply of copper for manufacturing products. To reduce the exposures to copper shortage, our Company enters into purchase contracts with commitment of monthly minimum purchase at market prices for selected operating units. The majority of these transactions take the form of contracts that are entered into and continue to be held for the purpose of receipt or delivery of the copper based on our Company’s expected purchase, sale or usage requirements. Such purchase commitment contracts are not deemed financial instruments or derivatives. To date, these contract positions have not had a material effect on our Company’s financial position, results of operations, and cash flow.

 

(ii)

Foreign currency risk

Our Company enters into foreign exchange forward contracts with the intention to reduce the foreign exchange risk of expected sales and purchase transactions. These contracts are entered into the periods consistent with foreign currency exposure of the underlying transaction, generally from one to 12 months. These contracts are not designated in hedge relationships, and are measured at fair value through profit or loss.

As of December 31, 2021 and 2020, our Company had outstanding forward contracts with notional amounts of $(42.1) million and $0 million, respectively. The outstanding forward contracts at December 31, 2021 mature between Jan. 27 and June 22, 2022, respectively. Our Company recognized gain (loss) on forward contracts as other income (expenses) – refer to Note 7(e) and Note 7(f).

The forward contract balance varies with the expected foreign currency transactions and changes in foreign exchange rate.

 

2021

 

2020

 

 

Assets

 

Liabilities

 

Assets

 

Liabilities

 

 

US$’000

 

US$’000

 

US$’000

 

US$’000

 

Foreign currency forward contracts

 

 

 

 

 

 

 

 

 

 

 

 

Fair value

 

249

 

 

 

 

 

 

 

 

11.

FINANCIAL ASSETS AND FINANCIAL LIABILITIES (continued)

11(d)Fair values

Set out below is a comparison of the carrying amounts and fair value of our Company’s financial instruments that are carried in the financial statements:

 

Carrying amount

 

Fair value

 

 

As of December 31,

 

As of December 31,

 

 

2021

 

2020

 

2021

 

2020

 

 

US$’000

 

US$’000

 

US$’000

 

US$’000

 

Financial assets-current

 

 

 

 

 

 

 

 

 

 

 

 

     Financial assets at amortized cost

 

 

 

 

 

 

 

 

 

 

 

 

    Cash and cash equivalents

 

44,507

 

 

52,237

 

 

44,507

 

 

52,237

 

    Financial assets at fair value at fair value through profit

 

249

 

 

 

 

249

 

 

 

    Trade receivables

 

103,564

 

 

82,071

 

 

103,564

 

 

82,071

 

    Other receivables

 

2,648

 

 

6,192

 

 

2,648

 

 

6,192

 

    Due from related parties

 

13,965

 

 

10,982

 

 

13,965

 

 

10,982

 

Financial assets-non-current

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets at fair value through other comprehensive income

 

2,929

 

 

2,271

 

 

2,929

 

 

2,271

 

Financial assets at amortized cost

 

 

 

 

 

 

 

 

 

 

 

 

    Long-term bank deposits*

 

1,725

 

 

1,879

 

 

1,725

 

 

1,879

 

Total

 

169,587

 

 

155,632

 

 

169,587

 

 

155,632

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities-current

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities at amortized cost

 

 

 

 

 

 

 

 

 

 

 

 

    Interest-bearing loans and borrowings

 

62,083

 

 

10,131

 

 

62,083

 

 

10,131

 

    Trade and other payables

 

44,784

 

 

27,370

 

 

44,784

 

 

27,370

 

    Due to related parties

 

11,865

 

 

10,620

 

 

11,865

 

 

10,620

 

    Accruals

 

23,374

 

 

21,361

 

 

23,374

 

 

21,361

 

    Lease liabilities

 

571

 

 

551

 

 

571

 

 

551

 

Financial liabilities-non-current

 

 

 

 

 

 

 

 

 

 

 

 

    Liabilities at amortized cost

 

 

 

 

 

 

 

 

 

 

 

 

       Interest-bearing loans and borrowings

 

3,304

 

 

3,650

 

 

3,304

 

 

3,650

 

    Lease liabilities

 

1,916

 

 

1,783

 

 

1,916

 

 

1,783

 

Total

 

147,897

 

 

75,466

 

 

147,897

 

 

75,466

 

* included in other non-current assets

 

 

(i)

Methods and assumptions used to estimate fair value

 

The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate the fair values:

 

Cash and cash equivalents, trade receivables, other receivables, due from related parties, trade and other payables, due to related parties, and financial lease liabilities approximate their carrying amounts largely due to the short-term maturities of these instruments.

 

Fixed-rate and variable-rate receivables are evaluated by our Company based on parameters such as interest rates, specific country risk factors, individual creditworthiness of the customer and the risk characteristics of the financed project. Based on this evaluation, allowances were provided to account for the expected losses of these receivables. As of December 31, 2021 and 2020, the carrying amounts of such receivables, net of allowances, were not materially different from their calculated fair values.

 

11.

FINANCIAL ASSETS AND FINANCIAL LIABILITIES (continued)

 

         11(d)   Fair values(continued)

 

(i)

Methods and assumptions used to estimate fair value (continued)

 

Fixed rate long-term bank deposits and fixed rate and variable-rate borrowings are evaluated using discounted cash flows and the market rates or current rates for deposits of similar remaining maturities.

 

Fair value of financial liabilities at fair value through profit or loss - derivatives is derived from inputs other than quoted prices that are observable for the asset or liability.

 

Fair value of interest-bearing borrowings and loans are determined by using discounted cash flow method with discount rate that reflects the issuer’s borrowing rate as of the end of the reporting period. The non-performance risk as of December 31, 2021 was assessed to be insignificant.

 

 

(ii)

Description of significant unobservable inputs to valuation

 

 

Valuation technique

Significant unobservable inputs

Liquidity discount

(2021 and 2020)

 

Sensitivity of the input to fair value

 

 

 

 

 

 

2021

2020

Financial asset

 

 

 

 

 

 

 

Unquoted equity instrument

Market Approach Method

Liquidity Discount

30%

 

5%  decrease in the discount would increase

in fair value by $209

5%  decrease in the discount would increase

in fair value by $162

Our Company estimates the fair value of investment in equity instrument by using the market approach (market comparatives approach). The key in this method is the selection of quoted comparable companies and accommodate adjustments to bring the accounts of different companies into a broadly consistent framework for analysis. Then, select appropriate Indicators of Value. The followings should be taken into account:

 

Enterprise Value (EV) versus Market Capitalization;

 

Earnings-based: EBITDA +/or EBIT versus Net Earnings +/or Net Cash Flow

 

Balance Sheet based: Net Total Assets versus Shareholders Funds

Discount for the lack of liquidity to reflect the lesser liquidity of this equity instrument compared with those of its comparable public company peers. Our Company assessed the discount for the lack of liquidity to be 30 percent on the basis of relevant studies applicable in the region and industry as well as on the specific facts and circumstances of the equity instrument. The equity instrument’s finance performance is characterized by stable, consistent growth and profitability. Our Company believes the liquidity discount of 30% would be appropriate.

 

 

11.     FINANCIAL ASSETS AND FINANCIAL LIABILITIES (continued)

 

         11(d)   Fair values (continued)

        (ii)     Description of significant unobservable inputs to valuation (continued)

Our Company carries the equity instrument as financial assets at fair value through other comprehensive income classified as level 3 within the fair value hierarchy.  A reconciliation of the beginning and closing balances is summarized below:

 

 

2021

 

2020

 

 

US$’000

 

US$’000

 

At January 1

 

2,271

 

 

4,062

 

Re-measurement financial assets to fair value, recognized in other comprehensive income/(loss)

 

734

 

 

(1,789

)

Exchange difference on translation

 

(76

)

 

(2

)

At December 31

 

2,929

 

 

2,271